Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC -1.66%87 Debt-to-EBITDA is 6.08 as of Dec. 2025, which is 2% above its 10-year median of 5.95. GuruFocus rates ASX:RHC with a GF Score™ of 87/100 and a GF Value™ of A$50.80 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 80.75% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Ramsay Health Care's Debt-to-EBITDA or its related term are showing as below:
ASX:RHC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.68 Med: 5.95 Max: 7.75
Current: 6.16
During the past 13 years, the highest Debt-to-EBITDA Ratio of Ramsay Health Care was 7.75. The lowest was 2.68. And the median was 5.95.
ASX:RHC's Debt-to-EBITDA is ranked worse than 80.75% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs ASX:RHC: 6.16
Ramsay Health Care (ASX:RHC) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Ramsay Health Care Debt-to-EBITDA Related Terms
Ramsay Health Care Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Ramsay Health Care's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:RHC vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Ramsay Health Care's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Ramsay Health Care (ASX:RHC) has a Debt-to-EBITDA of 6.08 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ramsay Health Care. This is near median its historical median of 5.95. Over the past decade, Ramsay Health Care's Debt-to-EBITDA has ranged from 2.68 to 7.75. According to the industry distribution chart, Ramsay Health Care ranks #386 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 80.8%.
Is Ramsay Health Care's Debt-to-EBITDA too high?
Ramsay Health Care's current Debt-to-EBITDA of 6.08 is near median its 10-year median of 5.95. Over the past 10 years, this metric has ranged from a low of 2.68 to a high of 7.75. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.25. Ramsay Health Care's value of 6.08 is 170.2% above this industry median. Based on the distribution chart, Ramsay Health Care ranks #386 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ramsay Health Care has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #386 out of 478 companies for Debt-to-EBITDA. This places Ramsay Health Care in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. Ramsay Health Care's value of 6.08 is 170.2% above this benchmark. Historically, Ramsay Health Care's own Debt-to-EBITDA has ranged from 2.68 to 7.75 over the past decade. While the company's 10-year median is 5.95 vs. the industry median of 2.25, Ramsay Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Health Care's current Debt-to-EBITDA of 6.08 is 170.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ramsay Health Care. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current Debt-to-EBITDA is 6.08, which is near median its own 10-year median of 5.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.80, compared to a current price of A$42.64 — trading 16.1% below its estimated fair value. The current Debt-to-EBITDA is 6.08, which is near median its 10-year median of 5.95 and 170.2% above the Healthcare Providers & Services industry median of 2.25. Ramsay Health Care's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Debt-to-EBITDA is 6.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued.
The current stock price of A$42.64 is trading 16.1% below its estimated GF Value™ of A$50.80.
GuruFocus considers Ramsay Health Care to be Modestly Undervalued.
Key valuation signals for ASX:RHC:
Debt-to-EBITDA: 6.08 (near median its 10-year median of 5.95)
GF Value™: A$50.80 vs. price of A$42.64 (16.1% below fair value)
Industry Position: 170.2% above the Healthcare Providers & Services median (#386 of 478)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
87GF Score
Get the complete analysis for ASX:RHC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
